MFDS — authorised 13 March 2007
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: likely_approved
🇰🇷 Tykerb in South Korea
MFDS authorised Tykerb on 13 March 2007
Marketing authorisation
Tykerb in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Tykerb approved in South Korea?
Yes. MFDS authorised it on 13 March 2007.
Who is the marketing authorisation holder for Tykerb in South Korea?
NOVARTIS PHARMS CORP holds the South Korean marketing authorisation.